+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Pharma R

Chromatography Reagents Market by Technology (LC (HPLC, UPLC, LPLC), GC, SFC, TLC), Type (Solvent (LC, GC), Derivatization Reagent (Acylation, Silylation), Ion-Pair Reagent, Buffer), Mechanism, User (Pharma, Academia, Hospital) - Forecast to 2029 - Product Thumbnail Image

Chromatography Reagents Market by Technology (LC (HPLC, UPLC, LPLC), GC, SFC, TLC), Type (Solvent (LC, GC), Derivatization Reagent (Acylation, Silylation), Ion-Pair Reagent, Buffer), Mechanism, User (Pharma, Academia, Hospital) - Forecast to 2029

  • Report
  • February 2024
  • 252 Pages
  • Global
From
Strategic Intelligence: Pharma M&A Deals Q3 2025 - Top Themes - Product Thumbnail Image

Strategic Intelligence: Pharma M&A Deals Q3 2025 - Top Themes

  • Report
  • October 2025
  • 27 Pages
  • Global
From
European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030 - Product Thumbnail Image

European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030

  • Report
  • September 2025
  • 477 Pages
  • Europe
From
Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • February 2026
  • 46 Pages
From
Regen BioPharma Inc (RGBP:PINX): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

Regen BioPharma Inc (RGBP:PINX): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 111 Pages
From
Pharma-bio Serv Inc (PBSV:PINX): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

Pharma-bio Serv Inc (PBSV:PINX): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 65 Pages
From
Athira Pharma Inc (ATHA:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

Athira Pharma Inc (ATHA:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 104 Pages
From
aTyr Pharma (ATYR:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

aTyr Pharma (ATYR:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 110 Pages
From
Inozyme Pharma Inc (INZY:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

Inozyme Pharma Inc (INZY:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 104 Pages
From
Lantern Pharma Inc (LTRN:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

Lantern Pharma Inc (LTRN:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 115 Pages
From
How to Prevent cGMP Violations & Warning letters - Training for Pharma Manufacturing - Product Thumbnail Image

How to Prevent cGMP Violations & Warning letters - Training for Pharma Manufacturing

  • Training
  • 8 Hours
  • Global
CTI BioPharma Corp (CTIC:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement, Market Size and Growth Forecasts - Product Thumbnail Image

CTI BioPharma Corp (CTIC:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement, Market Size and Growth Forecasts

  • Company Profile
  • April 2024
  • 86 Pages
From
Impel NeuroPharma Inc (IMPL:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement, Market Size and Growth Forecasts - Product Thumbnail Image

Impel NeuroPharma Inc (IMPL:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement, Market Size and Growth Forecasts

  • Company Profile
  • April 2024
  • 76 Pages
From
Pharma Mar SA (PHM) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharma Mar SA (PHM) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • November 2025
  • 53 Pages
From
Precision and Personalized Medicine in Pharma - Thematic Intelligence - Product Thumbnail Image

Precision and Personalized Medicine in Pharma - Thematic Intelligence

  • Report
  • June 2023
  • 62 Pages
  • Global
From
Integrated BioPharma Inc (INBP:PINX): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Thumbnail Image

Integrated BioPharma Inc (INBP:PINX): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Company Profile
  • July 2025
  • 110 Pages
From
Aurobindo Pharma Ltd. (AUROPHARMA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Aurobindo Pharma Ltd. (AUROPHARMA) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • November 2025
  • 64 Pages
From
Ultraviolet Visible Spectroscopy Market Size, Share & Trends by Offering (Instrument (Array, Single & Dual Beam), Software), Application (Environment. Air, Water, Soil), End User (Industry (F&B, Pharma, Biotech, Cosmetics. Chemicals), Labs) - Global Forecast to 2029 - Product Thumbnail Image

Ultraviolet Visible Spectroscopy Market Size, Share & Trends by Offering (Instrument (Array, Single & Dual Beam), Software), Application (Environment. Air, Water, Soil), End User (Industry (F&B, Pharma, Biotech, Cosmetics. Chemicals), Labs) - Global Forecast to 2029

  • Report
  • August 2024
  • 253 Pages
  • Global
From
Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) by Region - Overview of 2022 and Outlook for 2023 - Product Thumbnail Image

Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) by Region - Overview of 2022 and Outlook for 2023

  • Report
  • January 2023
  • 44 Pages
  • Global
From
GL Pharma GmbH - Strategic SWOT Analysis Review - Product Thumbnail Image

GL Pharma GmbH - Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2026
  • 20 Pages
From
Loading Indicator